Background: Parents of young children with type 1 diabetes (PYC-T1D) may be susceptible to poor sleep due to the 24/7 demands of diabetes care and concerns about overnight hypoglycemia, yet sleep patterns of PYC-T1D shortly after T1D diagnosis have not been reported. We aimed to describe the sleep of PYC-T1D in the first 2 months post-diagnosis and explore any differences with continuous glucose monitor (CGM) use.
Methods: Participants were 157 PYC-T1D (M child age=4.5±1.6 years, 90% mothers, 61% White/non-Hispanic) assessed at baseline (M duration=27±15 days) of a behavioral RCT. Parents self-reported about sleep (Pittsburgh Sleep Quality Index, PSQI), T1D-specific sleep disruptions, and children’s use of CGM (20%). We report descriptive statistics for the full sample and compared by CGM use (independent t-test, X2).
Results: Most (80%) PYC-T1D had PSQI≥5 indicating clinically significant sleep disturbance (M=8.3±4.1). Mean sleep duration was 5.9±1.4 hours/night. Table 1 shows over 2/3 reported T1D-related sleep disruptions and presents comparisons between CGM groups.
Conclusion: Sleep disruption is a pervasive problem among PYC-T1D soon after diagnosis, with the majority not meeting recommendations for sleep duration and having clinically elevated sleep disturbances. Though some aspects of sleep disruption were higher in CGM users, we cannot infer causality and poor sleep was prevalent regardless of CGM use.
I. Al-Gadi: None. R. Streisand: None. M. Monaghan: Research Support; Self; American Diabetes Association. C. Tully: None. M. Sinisterra: None. M.E. Hilliard: None.
National Institutes of Health (1R01DK102561)